Related Experiment Video
Updated: May 27, 2026

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Published on: September 7, 2017
Hypomethylation of repeated DNA sequences in cancer
Jason P Ross1, Keith N Rand, Peter L Molloy
1Commonwealth Scientific & Industrial Research Organisation, Food & Nutritional Science, Preventative Health National Research Flagship, North Ryde, NSW 1670, Australia.
Abstract:
An important feature of cancer development and progression is the change in DNA methylation patterns, characterized by the hypermethylation of specific genes concurrently with an overall decrease in the level of 5-methylcytosine. Hypomethylation of the genome can affect both single-copy genes, repeat DNA sequences and transposable elements, and is highly variable among and within cancer types. Here, we review our current understanding of genome hypomethylation in cancer, with a particular focus on hypomethylation of the different classes and families of repeat sequences. The emerging data provide insights into the importance of methylation of different repeat families in the maintenance of chromosome structural integrity and the fidelity of normal transcriptional regulation. We also consider the events underlying cancer-associated hypomethylation and the potential for the clinical use of characteristic DNA methylation changes in diagnosis, prognosis or classification of tumors.
Insights
Cancer DNA methylation changes, including genome hypomethylation, impact gene expression and chromosome stability. Understanding these patterns may aid in tumor diagnosis and prognosis.
Area of Science:
- Epigenetics and Genomics
- Cancer Biology
Background:
- Cancer development involves altered DNA methylation, with gene hypermethylation and global 5-methylcytosine decrease.
- Genome hypomethylation in cancer affects single-copy genes, repeats, and transposable elements, showing significant variability.
Purpose of the Study:
- To review current knowledge on genome hypomethylation in cancer.
- To focus on the hypomethylation of various repeat sequence classes and families.
- To explore the clinical potential of DNA methylation changes in cancer.
Main Methods:
- Literature review of studies on genome hypomethylation in cancer.
- Analysis of data concerning repeat sequence methylation and its functional implications.
- Discussion of underlying mechanisms and clinical applications of DNA methylation alterations.
Main Results:
- Hypomethylation of repeat sequences is crucial for maintaining chromosome structure and transcriptional regulation.
- Emerging data highlight the significance of repeat family methylation in cancer.
Conclusions:
- Genome hypomethylation, particularly of repeat sequences, plays a critical role in cancer progression.
- Understanding these epigenetic changes offers potential for novel diagnostic, prognostic, and classification tools in oncology.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cancers Originate from Somatic Mutations in a Single Cell
Replicative Cell Senescence
Abnormal Proliferation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...

